Universal solution for drug development
Engineered ARMMs provide a flexible platform for therapeutic delivery with the potential to overcome the limitations of existing technologies—including toxicity, low specificity, instability, and high immunogenicity associated with lipid nanoparticles (LNPs), viral vectors, transducing peptides, and nano-carriers.
Vesigen’s ARMMS system also offers important advantages over exosomes, LNPs, penetrating peptides, and viral delivery systems:
- Broad tissue distribution observed in vivo
- Production of payload and delivery technology in a single process
- Scalable production system using common upstream and downstream biologics process technologies
- Superior engineerability with applications to broad therapeutic classes